1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Opioids Market Overview to 2023 - Opioids in Western Europe

Opioids Market Overview to 2023 - Opioids in Western Europe

  • October 2014
  • -
  • CBR Pharma Insights
  • -
  • 74 pages

Opioids Market Overview to 2023 - Opioids in Western Europe

Summary

The report provides an estimation of 2013 opioid revenues and forecast consumption and revenues until 2023 in the five major Western European countries: the UK, Germany, France, Italy and Spain. The estimated revenues for 2013 are highest in the UK, which held a share of 52%, followed by Germany with 20%. Spain had the lowest in terms of both consumption (3.3%) and revenues (2.2%).

Their use for medicinal purposes has been highly controversial for several decades. Although recognized as potent painkillers, potential for misuse is high. As a result, all regulatory authorities strive to maintain a fine balance between enforcing strict regulations that will crack down on illicit usage but at the same time ensure accessibility for genuine medical purposes. Amidst concerns regarding inadequate pain management due to low accessibility, there are also concerns regarding a lack of significant clinical evidence of their role in managing chronic pain. However, new abuse-deterrent technologies provide an incentive to prescribe more opioids in pain management by alleviating concerns over misuse potential. The approval of such new drugs and formulations has proved a new impetus to growth in opioid usage in the five major Western European countries.

Opioids are largely used for two medicinal purposes: pain management and substitution treatment for drug dependence. Several of the recently approved and pipeline opioid analgesics have a strong focus on reducing misuse potential, which is one of the most significant barriers to usage in pain management. However, usage is on the rise following the introduction of new abuse-deterrent formulations of fentanyl and oxycodone, and initiatives that aim to rationalize usage in pain management. Demand is also high in substitution treatment. While both methadone and buprenorphine are approved for substitute treatment, buprenorphine usage increased in Europe after the approval of Suboxone in 2006, in combination with naloxone, a pure opioid antagonist that acts as an abuse-deterrent.

Scope

The report covers the five major Western European countries (the UK, Germany, France, Italy and Spain) and includes -
- An overview of opioids in pain management and substitution treatment, and usage constraints for both
- Brief analysis of recent approvals of key abuse-deterrent drugs and their impact on consumption and market growth
- Country snapshots, comprising key regulations, consumption, market revenues, market forecasts and key drivers and barriers
- An overview of new abuse-deterrent technologies and profiles of key pipeline products

Key Reasons to Purchase

- Gain a perspective of the opioids market size and key drivers and challenges that dictate the market trends in each of the five major countries in Western Europe
- Gauge the impact of key recently approved abuse-deterrent technologies on opioid usage
- Develop an understanding of how the regulatory landscape affects market potential and growth in each country
- Identify the key molecules that are currently the leading players in each region and those that hold the highest potential in the forecast period
- Scan the pipeline for innovative products with abuse-deterrent technologies that could have an impact on opioid usage in the pain management market

Table Of Contents

Opioids Market Overview to 2023 - Opioids in Western Europe
Executive summary
Opioids: an overview
Opioids in pain management
Usage constraints
International conventions
Drug misuse in Western Europe
Extent of drug misuse
Impact of abuse-deterrent drugs
Key abuse-deterrent products
Unmet need in pain management
Requirement and consumption
Key activities to promote usage
Regulatory landscape
Finding a balance between accessibility and regulations
Opioids market in Europe
Consumption trends in Europe
Estimated revenue and forecast
Country snapshots (UK, Germany, France, Italy, Spain)
Regulatory landscape
Consumption trends
Volume and revenue by molecule
Barriers and activities to rationalize usage
Market developments
Leading global brands
New abuse-deterrent technologies
Pipeline products
New developments
Strategic consolidations
Appendix
Abbreviations/acronyms
References

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes

Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes

  • $ 6995
  • Industry report
  • August 2016
  • by GBI Research

Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes Summary Pain, and in particular chronic pain, ...

North America Opioid Market Analysis By Product, By Application And Segment Forecasts To 2024

North America Opioid Market Analysis By Product, By Application And Segment Forecasts To 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The North America opioid market is expected to reach USD 18.5 billion by 2024, according to a new report by Grand View Research, Inc. Favorable regulations and healthcare reforms are providing an environment, ...

Global Market Study on Opioids: Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period

Global Market Study on Opioids: Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period

  • $ 4900
  • Industry report
  • August 2016
  • by Persistence Market Research

Opioids are naturally occurring opiates and synthetic and semi-synthetic drugs that act on opioid receptors in the brain and can cause dependence due to their euphoric effects. Opioids are majorly categorized ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US - Forecast

  • November 2016
    6 pages
  • Therapy  

    Opioid  

  • United States  

View report >

Analgesic Market in the UK

  • November 2016
    10 pages
  • Analgesic  

  • United Kingdom  

View report >

Opioid Market in the US

  • November 2016
    2 pages
  • Opioid  

  • United States  

    World  

    North America  

View report >

Related Market Segments :

Opioid
Analgesic

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.